Improved Pharma

Executive Summary

Improved Pharma is a privately held research and consulting company specializing in pharmaceutical formulation design, solid-state characterization, and analytical testing. Founded in 2006 by industry veterans Stephen and Sarah Byrn, the firm leverages deep expertise in synchrotron techniques and intellectual property defense to support drug development and patent litigation. With a focus on improving pharmaceutical methods and processes, Improved Pharma serves as a strategic partner for both innovator and generic drug companies. The company's service-based model generates recurring revenue through contracts, but its lack of proprietary drug pipelines and public funding limits visibility into growth catalysts. As a private entity, financial performance and operational milestones are not publicly disclosed, making it difficult to assess near-term value creation.